SCHEMBL1127568

SCHEMBL1127568

CCC1(COc2ccc3ccccc3c2)COC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGXT P21549 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2A6 P11509 1/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALOX5 P09917 3/20 0.42
RAB9A P51151 2/20 0.41
PTPN7 P35236 1/20 0.41
DRD3 P35462 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
PPARG P37231 2/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR3A P46098 1/20 0.39
KCNH2 Q12809 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29366776 1.00 AGXT (0.45) AGXTCYP1A2CYP2A6KDM4EMAPK1
SCHEMBL14091340 0.95 AGXT (0.40) AGXTCYP1A2CYP2A6KDM4EMAPK1
SCHEMBL29448188 0.94 TSHR (0.38) AGXTCYP1A2CYP2A6KDM4EMAPK1
SCHEMBL36312 0.94 TSHR (0.38) AGXTCYP1A2CYP2A6KDM4EMAPK1
SCHEMBL21089716 0.88 TSHR (0.36) AGXTCYP1A2KDM4EALOX5MEN1
SCHEMBL14087673 0.87 TSHR (0.38) CYP1A2KDM4EALOX5RAB9AMEN1
SCHEMBL36036 0.84 TSHR (0.45) KDM4EMAPK1ALOX5MEN1KMT2A
SCHEMBL36226 0.84 TSHR (0.40) CYP1A2MAPK1TDP1HRH3MEN1
SCHEMBL21747579 0.83 TSHR (0.32) KDM4EALOX5TSHRSMN1; SMN2
SCHEMBL36030 0.82 MEN1 (0.41) TDP1MEN1KMT2ALMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4667537-A1 PRIMER COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE TOKYO OHKA KOGYO CO., LTD. (JP) 2025-12-24 EP disclosed
US-20250382500-A1 PRIMER COMPOSITION, LAMINATE, AND METHOD FOR PRODUCING LAMINATE TOKYO OHKA KOGYO CO LTD (JP) 2025-12-18 US disclosed
EP-1964893-B2 Ink composition, inkjet recording method, printed material, and ink set FUJIFILM CORP (JP) 2021-11-24 EP disclosed
EP-3199520-B1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO LTD (JP) 2019-12-25 EP disclosed
US-10059662-B2 Sulfonium salt, photoacid generator, and photosensitive composition TOKYO OHKA KOGYO CO., LTD. (JP) 2018-08-28 US disclosed
EP-1964893-B1 Ink composition, inkjet recording method, printed material, and ink set FUJIFILM CORP (JP) 2018-01-24 EP disclosed
US-20170305848-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2017-10-26 US disclosed
EP-3199520-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION Tokyo Ohka Kogyo Co., Ltd. (JP) 2017-08-02 EP disclosed
EP-2284165-B1 SULFONIUM SALT, PHOTOACID GENERATOR, PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT OF THE PHOTO-CURABLE COMPOSITION SAN APRO LTD (JP) 2013-02-20 EP disclosed
US-8278030-B2 Sulfonium salt, photoacid generator, and photocurable composition and cured body thereof SAN-APRO LIMITED (JP) 2012-10-02 US disclosed
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF SAN-APRO LIMITED (JP) 2011-02-17 US disclosed
EP-2284165-A1 PHOSPHONIUM SALT, PHOTOACID GENERATOR, PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT OF THE PHOTO-CURABLE COMPOSITION San-Apro Limited (JP) 2011-02-16 EP disclosed
EP-1964893-A1 Ink composition, inkjet recording method, printed material, and ink set FUJIFILM Corporation (JP) 2008-09-03 EP disclosed
US-20080206527-A1 INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, AND INK SET FUJIFILM CORPORATION (JP) 2008-08-28 US disclosed
US-20080206527-A1 INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATERIAL, AND INK SET FUJIFILM CORPORATION (JP) 2008-08-28 US disclosed
EP-1069120-B1 Naphthalene derivative, binaphthalene derivative and biphenyl derivative and cationically curable compound TOAGOSEI CO LTD (JP) 2003-08-13 EP disclosed
US-6469108-B2 REACTING A DIHYDROXYNAPHTHALENE WITH 3-ALKYL-3-CHLOROMETHYLOXETANE OR 3-CHLOROMETHYLOXETANE IN PRESENCE OF ALKALI METAL HYDROXIDE, ALKALI METAL HYDRIDE OR ALKALI METAL TOAGOSEI CO., LTD. (JP) 2002-10-22 US disclosed
US-20020103330-A1 Naphthalene derivative, binaphthalene derivative and biphenyl derivative and cationically curable compound TOAGOSEI CO., LTD. 2002-08-01 US disclosed
US-6365760-B1 BIS(3-ALKYLOXETAN-3-YL)-METHOXY)BIPHENYL COMPOUNDS USED AS OPTICAL MATERIALS; WORKABILITY; LOW VISCOSITY; HIGH REFRACTIVE INDEX; PHOTO AND THERMOCURING; TOAGOSEI CO., LTD. (JP) 2002-04-02 US disclosed
EP-1069120-A1 Naphthalene derivative, binaphthalene derivative and biphenyl derivative and cationically curable compound TOAGOSEI CO., LTD. (JP) 2001-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170305848-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOSENSITIVE COMPOSITION ARSA, SPIN1, ASIC1 AGXT 2157/4885CYP1A2 1693/4885CYP2A6 1791/4885
US-10059662-B2 Sulfonium salt, photoacid generator, and photosensitive composition ARSA, SPIN1, ASIC1 AGXT 2157/4885CYP1A2 1693/4885CYP2A6 1791/4885
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF ARSA, ASIC1, TST AGXT 1313/4885CYP1A2 2434/4885CYP2A6 2346/4885
US-20020103330-A1 Naphthalene derivative, binaphthalene derivative and biphenyl derivative and cationically curable compound NDC1, BECN1, NUCB2 AGXT 3850/4885CYP1A2 430/4885CYP2A6 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.